Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone (vol 5, pg 61, 2000)

被引：0
|
作者：
Huber, J
Foidart, JM
Wuttke, W
Merki-Field, GS
The, HS
Gerlinger, C
Schellschmidt, I
Heithecker, R
机构：
来源：
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE | 2001年 / 6卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [41] Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism
    Agren, Ulla M.
    Anttila, Marjatta
    Maenpaa-Liukko, Kristiina
    Rantala, Maija-Liisa
    Rautiainen, Hilkka
    Sommer, Werner F.
    Mommers, Ellen
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2011, 16 (06): : 444 - 457
  • [42] Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies (vol 124, pg 1490, 2017)
    Larivee, N.
    Suissa, S.
    Khosrow-Khavar, F.
    Tagalakis, V
    Filion, K. B.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 125 (07) : 910 - 910
  • [43] Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 g gestodene
    Endrikat, J
    Gerlinger, C
    Cronin, M
    Ruebig, A
    Schmidt, W
    Düsterberg, B
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2001, 6 (03): : 159 - 166
  • [44] Efficacy and Safety of the Combined Oral Contraceptive Ethinylestradiol/ Drospirenone (Yasmin®) in Healthy Chinese WomenA Randomized, Open-Label, Controlled, Multicentre Trial
    Fan Guang-Sheng
    Bian Mei-Lu
    Cheng Li-Nan
    Cao Xiao-Ming
    Huang Zi-Rong
    Han Zi-Yan
    Jing Xiao-Ping
    Li Jian
    Wu Shu-Ying
    Xiong Cheng-Liang
    Xiong Zheng-Ai
    Yue Tian-Fu
    [J]. Clinical Drug Investigation, 2010, 30 : 387 - 396
  • [45] Repaglinide: a novel oral antidiabetic acid (vol 61, pg 112, 2000)
    不详
    [J]. HOSPITAL MEDICINE, 2000, 61 (03): : 217 - 217
  • [46] Efficacy and Safety of the Combined Oral Contraceptive Ethinylestradiol/Drospirenone (Yasmin®) in Healthy Chinese Women A Randomized, Open-Label, Controlled, Multicentre Trial
    Fan Guang-Sheng
    Bian Mei-Lu
    Cheng Li-Nan
    Cao Xiao-Ming
    Huang Zi-Rong
    Han Zi-Yan
    Jing Xiao-Ping
    Li Jian
    Wu Shu-Ying
    Xiong Cheng-Liang
    Xiong Zheng-Ai
    Yue Tian-Fu
    [J]. CLINICAL DRUG INVESTIGATION, 2010, 30 (06) : 387 - 396
  • [47] Efficacy and tolerability of the dienogest-containing oral contraceptive Valette®.: Results of a postmarketing surveillance study
    Zimmermann, T
    Dietrich, H
    Wisser, KH
    Hoffmann, H
    [J]. DRUGS OF TODAY, 1999, 35 : 79 - 87
  • [48] Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen
    Brucker, Cosima
    Hedon, Bernard
    The, Hok Sien
    Hoeschen, Kornelia
    Binder, Natascha
    Christoph, Annette
    [J]. CONTRACEPTION, 2010, 81 (06) : 501 - 509
  • [49] Efficacy and safety of an oral contraceptive containing ethinylestradiol 20 mu g/drospirenone 3 mg (24/4 regimen) in three indications in the People's Republic of China: a comparison with international studies
    Marr, Joachim
    Huang, Zirong
    Wang, Baoxi
    Zhang, Hongyan
    Roth, Katrin
    [J]. OPEN ACCESS JOURNAL OF CONTRACEPTION, 2015, 6 : 95 - 104
  • [50] MULTICENTER STUDY IN HUNGARY WITH A 30-MU-G ETHINYLESTRADIOL-CONTAINING AND 150-MU-G DESOGESTREL-CONTAINING MONOPHASIC ORAL-CONTRACEPTIVE
    BRUYNIKS, N
    KOVACS, L
    RAKOCZI, I
    [J]. ADVANCES IN CONTRACEPTION, 1994, 10 (03) : 175 - 185
12345